Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamine

Bibliographic Details
Main Authors:	Murilo S. de Abreu, Ashton J. Friend, Tamara G. Amstislavskaya, Allan V. Kalueff
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-04-01
Series:	Frontiers in Pharmacology
Subjects:	scopolamine Zebrafish anxiety hallucinogens animal models
Online Access:	http://journal.frontiersin.org/article/10.3389/fphar.2018.00293/full

id	doaj-db34a812ee27460e8cdd03f4497f0193
record_format	Article
spelling	doaj-db34a812ee27460e8cdd03f4497f01932020-11-24T23:15:38ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-04-01910.3389/fphar.2018.00293363164Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamineMurilo S. de Abreu0Murilo S. de Abreu1Murilo S. de Abreu2Ashton J. Friend3Ashton J. Friend4Tamara G. Amstislavskaya5Allan V. Kalueff6Allan V. Kalueff7Allan V. Kalueff8Allan V. Kalueff9Allan V. Kalueff10Allan V. Kalueff11Allan V. Kalueff12Bioscience Institute, University of Passo Fundo, Passo Fundo, BrazilPostgraduate Program in Pharmacology, Federal University of Santa Maria, Santa Maria, BrazilNeuroscience Program, School of Science and Engineering, Tulane University, New Orleans, LA, United StatesNeuroscience Program, School of Science and Engineering, Tulane University, New Orleans, LA, United StatesThe International Zebrafish Neuroscience Research Consortium, Slidell, LA, United StatesResearch Institute of Physiology and Basic Medicine, Novosibirsk, RussiaSchool of Pharmacy, Southwest University, Chongqing, ChinaInstitute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, RussiaInstitute of Experimental Medicine, Almazov National Medical Research Center, St. Petersburg, RussiaUral Federal University, Ekaterinburg, Russia0Russian National Granov's Research Center for Radiology and Surgical Technologies, Pesochny, Russia1Laboratory of Translational Biopsychiatry, Research Institute of Physiology and Basic Medicine, Novosibirsk, Russia2ZENEREI Research Center, Slidell, LA, United Stateshttp://journal.frontiersin.org/article/10.3389/fphar.2018.00293/fullscopolamineZebrafishanxietyhallucinogensanimal models
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Murilo S. de Abreu Murilo S. de Abreu Murilo S. de Abreu Ashton J. Friend Ashton J. Friend Tamara G. Amstislavskaya Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff
spellingShingle	Murilo S. de Abreu Murilo S. de Abreu Murilo S. de Abreu Ashton J. Friend Ashton J. Friend Tamara G. Amstislavskaya Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamine Frontiers in Pharmacology scopolamine Zebrafish anxiety hallucinogens animal models
author_facet	Murilo S. de Abreu Murilo S. de Abreu Murilo S. de Abreu Ashton J. Friend Ashton J. Friend Tamara G. Amstislavskaya Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff Allan V. Kalueff
author_sort	Murilo S. de Abreu
title	Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamine
title_short	Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamine
title_full	Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamine
title_fullStr	Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamine
title_full_unstemmed	Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamine
title_sort	commentary: establishing zebrafish as a model to study the anxiolytic effects of scopolamine
publisher	Frontiers Media S.A.
series	Frontiers in Pharmacology
issn	1663-9812
publishDate	2018-04-01
topic	scopolamine Zebrafish anxiety hallucinogens animal models
url	http://journal.frontiersin.org/article/10.3389/fphar.2018.00293/full
work_keys_str_mv	AT murilosdeabreu commentaryestablishingzebrafishasamodeltostudytheanxiolyticeffectsofscopolamine AT murilosdeabreu commentaryestablishingzebrafishasamodeltostudytheanxiolyticeffectsofscopolamine AT murilosdeabreu commentaryestablishingzebrafishasamodeltostudytheanxiolyticeffectsofscopolamine AT ashtonjfriend commentaryestablishingzebrafishasamodeltostudytheanxiolyticeffectsofscopolamine AT ashtonjfriend commentaryestablishingzebrafishasamodeltostudytheanxiolyticeffectsofscopolamine AT tamaragamstislavskaya commentaryestablishingzebrafishasamodeltostudytheanxiolyticeffectsofscopolamine AT allanvkalueff commentaryestablishingzebrafishasamodeltostudytheanxiolyticeffectsofscopolamine AT allanvkalueff commentaryestablishingzebrafishasamodeltostudytheanxiolyticeffectsofscopolamine AT allanvkalueff commentaryestablishingzebrafishasamodeltostudytheanxiolyticeffectsofscopolamine AT allanvkalueff commentaryestablishingzebrafishasamodeltostudytheanxiolyticeffectsofscopolamine AT allanvkalueff commentaryestablishingzebrafishasamodeltostudytheanxiolyticeffectsofscopolamine AT allanvkalueff commentaryestablishingzebrafishasamodeltostudytheanxiolyticeffectsofscopolamine AT allanvkalueff commentaryestablishingzebrafishasamodeltostudytheanxiolyticeffectsofscopolamine
_version_	1725590052058169344

Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamine

Similar Items